Reader in Microbial Pathogenesis
University of Sussex, UK
Tel: 01273 877572
TB, transcriptomics, host-pathogen interactions
The Waddell lab uses genome-wide technologies (particularly transcriptomics) to understand TB drug action during human disease, to define M.tuberculosis populations that survive early drug therapy, and to identify the mode of action of novel anti-mycobacterial compounds. Our research also explores the interactions between host and pathogen throughout the disease process using transcriptional signatures derived from immune cells and M.tuberculosis to reveal new pathways and novel antigens to target.
Profile page on BSMS